A Double-blind, Randomized, Multi-center Phase III Clinical Trial to Investigate the Safety and Efficacy Between YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia
Phase of Trial: Phase III
Latest Information Update: 04 Aug 2014
At a glance
- Drugs Rosuvastatin/telmisartan (Primary) ; Rosuvastatin; Telmisartan
- Indications Hypercholesterolaemia; Hyperlipidaemia; Hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Yuhan
- 07 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 15 Jan 2014 Status changed from not yet recruiting to recruiting as reported in ClinicalTrials.gov record.
- 06 Aug 2013 New trial record